31 related articles for article (PubMed ID: 38676285)
1. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.
Ivell R; Heng K; Severn K; Antonio L; Bartfai G; Casanueva FF; Huhtaniemi IT; Giwercman A; Maggi M; O'Connor DB; O'Neill TW; Punab M; Rastrelli G; Slowikowska-Hilczer J; Tournoy J; Vanderschueren D; Wu FCW; Anand-Ivell R
Front Endocrinol (Lausanne); 2022; 13():1016107. PubMed ID: 36425465
[TBL] [Abstract][Full Text] [Related]
2. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort.
Anand-Ivell R; Heng K; Severn K; Antonio L; Bartfai G; Casanueva FF; Huhtaniemi IT; Giwercman A; Maggi M; O'Neill TW; Punab M; Rastrelli G; Slowikowska-Hilczer J; Tournoy J; Vanderschueren D; Wu FCW; Ivell R
Andrology; 2022 Oct; 10(7):1328-1338. PubMed ID: 35770372
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function.
Albrethsen J; Johannsen TH; Jørgensen N; Frederiksen H; Sennels HP; Jørgensen HL; Fahrenkrug J; Petersen JH; Linneberg A; Nordkap L; Bang AK; Andersson AM; Juul A
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32211773
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold.
Anand-Ivell R; Heng K; Antonio L; Bartfai G; Casanueva FF; Maggi M; O'Neill TW; Punab M; Rastrelli G; Slowikowska-Hilczer J; Tournoy J; Vanderschueren D; Wu FC; Huhtaniemi IT; Ivell R
Aging Male; 2024 Dec; 27(1):2346322. PubMed ID: 38676285
[TBL] [Abstract][Full Text] [Related]
6. INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network.
Facondo P; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A
Protein Pept Lett; 2020; 27(12):1246-1252. PubMed ID: 32981493
[TBL] [Abstract][Full Text] [Related]
7. INSL3 as a biomarker of Leydig cell functionality.
Ivell R; Wade JD; Anand-Ivell R
Biol Reprod; 2013 Jun; 88(6):147. PubMed ID: 23595905
[TBL] [Abstract][Full Text] [Related]
8. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders.
Bay K; Andersson AM
Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598
[TBL] [Abstract][Full Text] [Related]
9. Biology of insulin-like factor 3 in human reproduction.
Ivell R; Anand-Ivell R
Hum Reprod Update; 2009; 15(4):463-76. PubMed ID: 19329805
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Factor 3 and the HPG Axis in the Male.
Ivell R; Heng K; Anand-Ivell R
Front Endocrinol (Lausanne); 2014; 5():6. PubMed ID: 24478759
[TBL] [Abstract][Full Text] [Related]
11. Testicular function and bone metabolism--beyond testosterone.
Ferlin A; Selice R; Carraro U; Foresta C
Nat Rev Endocrinol; 2013 Sep; 9(9):548-54. PubMed ID: 23856820
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
